X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Delta Cargos new high-tech cooler allows safer transportation of vaccines

Content Team by Content Team
6th November 2020
in News, Packaging & Logistic
Delta Cargos new high-tech cooler allows safer transportation of vaccines

The safe, reliable and efficient transportation of pharmaceutical products is a key focus for Delta Cargo. To support that goal, the airline has approved the DoKaSch Opticooler RAP container for use on Delta aircraft as part of its cold chain pharma program for the safe transportation of vaccines.

This high-end, state-of-the-art climate-control solution offers pharmaceutical and life science companies a controlled and reliable 2-8°C and 15-25°C options, enabling it to be used for Pharma 1 transportation including vaccines, without the need for dry ice. The Opticooler has a large control panel plus quadruple redundancy for all critical parts, meaning there are backups for each feature in case of failure. The large loading compartment easily accommodates five standard Euro pallets or four CP-1 pallets, plus the container has a large battery operating independently up to 120 hours and requires merely 2 to 4 hours battery-charging time.

“The introduction of the Opticooler provides our customers with more choice when looking for reliable container options to support the growing global demand for pharma and vaccine shipments,” said Shawn Cole, Delta’s Vice President — Cargo. “Alongside our joint venture partners, Air France-KLM Cargo, we can now offer our customers a seamless experience across the trans-Atlantic, helping to keep supply chains moving and ensuring the safe delivery of temperature sensitive shipments during the current pandemic.”

Andreas Seitz, Managing Director of DoKaSch Temperature Solutions, said, “This agreement with Delta provides more transport options for shippers of sensitive pharmaceutical goods, which is especially important for the upcoming transport of vaccines against COVID-19. Many of these will require a temperature range between 2°C and 8°C during transport, which is exactly what our Opticooler is made for. Delta further expands our extensive global network which allows us to offer our temperature-controlled packaging solutions at even more locations.”

Delta Cargo was the first U.S. passenger carrier to receive IATA’s Center of Excellence for Independent Validators (CEIV) Pharma Logistics Certification. This award means that we are compliant, in our Atlanta warehouse and at 49 Pharma approved airports across the globe, provided through our handling partners. We have also expanded our cooler facilities at the Atlanta warehouse, ensuring we provide the highest industry standards for the shipment of pharmaceuticals, vaccines and life sciences across our network.

Previous Post

Ethiopian Cargo Pharma Wing ready to distribute the Covid-19 vaccine

Next Post

FCS Frankfurt Cargo Services receives another important pharma certification

Related Posts

SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Next Post
FCS Frankfurt Cargo Services receives another important pharma certification

FCS Frankfurt Cargo Services receives another important pharma certification

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In